BlackRock’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $433M | Sell |
|
|||||
|
2025
Q2 | $445M | Sell |
|
|||||
|
2025
Q1 | $355M | Buy |
|
|||||
|
2024
Q4 | $234M | Sell |
|
|||||
|
2024
Q3 | $197M | Buy |
|
|||||
|
2024
Q2 | $196M | Buy |
|
|||||
|
2024
Q1 | $216M | Buy |
|
|||||
|
2023
Q4 | $357M | Buy |
|
|||||
|
2023
Q3 | $209M | Sell |
|
|||||
|
2023
Q2 | $240M | Buy |
|
|||||
|
2023
Q1 | $186M | Sell |
|
|||||
|
2022
Q4 | $163M | Buy |
|
|||||
|
2022
Q3 | $163M | Buy |
|
|||||
|
2022
Q2 | $137M | Sell |
|
|||||
|
2022
Q1 | $241M | Sell |
|
|||||
|
2021
Q4 | $235M | Sell |
|
|||||
|
2021
Q3 | $169M | Buy |
|
|||||
|
2021
Q2 | $247M | Buy |
|
|||||
|
2021
Q1 | $191M | Buy |
|
|||||
|
2020
Q4 | $387M | Buy |
|
|||||
|
2020
Q3 | $295M | Sell |
|
|||||
|
2020
Q2 | $376M | Sell |
|
|||||
|
2020
Q1 | $428M | Sell |
|
|||||
|
2019
Q4 | $438M | Buy |
|
|||||
|
2019
Q3 | $343M | Sell |
|
|||||
|
2019
Q2 | $258M | Sell |
|
|||||
|
2019
Q1 | $288M | Buy |
|
|||||
|
2018
Q4 | $164M | Buy |
|
|||||
|
2018
Q3 | $203M | Buy |
|
|||||
|
2018
Q2 | $149M | Buy |
|
|||||
|
2018
Q1 | $149M | Sell |
|
|||||
|
2017
Q4 | $202M | Buy |
|
|||||
|
2017
Q3 | $241M | Buy |
|
|||||
|
2017
Q2 | $156M | Buy |
|
|||||
|
2017
Q1 | $187M | Buy |
|
|||||
|
2016
Q4 | $2.84M | Buy |
|
|||||
|
2016
Q3 | $428K | Buy |
|
|||||
|
2016
Q2 | $401K | Buy |
|
|||||
|
2016
Q1 | $152K | Buy |
|
|||||
|
2015
Q4 | $81K | Buy |
|
|||||
|
2015
Q3 | $57K | Sell |
|
|||||
|
2015
Q2 | $86K | Sell |
|
|||||
|
2015
Q1 | $68K | Hold |
|
|||||
|
2014
Q4 | $66K | Sell |
|
|||||
|
2014
Q3 | $60K | Hold |
|
|||||
|
2014
Q2 | $55K | Sell |
|
|||||
|
2014
Q1 | $61K | Buy |
|
|||||
|
2013
Q4 | $59K | Hold |
|
|||||
|
2013
Q3 | $65K | Sell |
|
|||||
|
2013
Q2 | $784K | Buy |
|